MAP
VIVO

Moody Aldrich Partners’s Meridian Bioscience Inc VIVO Stock Holding History

Moody Aldrich Partners’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-137,075
Closed -$3.04M – 190
2021
Q2 		$3.04M Sell
137,075
-1,769
-1% -$37.5K 0.43% 83
2021
Q1 		$3.65M Buy
138,844
+2,973
+2% +$70.7K 0.53% 74
2020
Q4 		$2.54M Sell
135,871
-779
-0.6% -$14.5K 0.41% 86
2020
Q3 		$2.32M Buy
136,650
+81,440
+148% +$1.58M 0.49% 85
2020
Q2 		$1.29M Buy
+55,210
New +$800K 0.27% 94

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Moody Aldrich Partners's VIVO Position: Q3 2021 in Review

Moody Aldrich Partners sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 137,075 shares — an estimated $3.04M sold.

Moody Aldrich Partners first reported a position in VIVO in Q2 2020 and held it in 5 quarters. The position peaked at $3.65M in Q1 2021. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • Moody Aldrich Partners reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • Moody Aldrich Partners sold 137,075 Meridian Bioscience Inc shares in Q3 2021, an estimated $3.04M.
  • Moody Aldrich Partners first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 5 quarters.
  • Moody Aldrich Partners's Meridian Bioscience Inc position peaked at $3.65M in Q1 2021.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on Moody Aldrich Partners's 13F filing for Q3 2021, filed 29 Oct 2021.